About this Journal Submit a Manuscript Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 467682, 3 pages
http://dx.doi.org/10.1155/2013/467682
Editorial

Cardiometabolic Diseases and Related Complications: Current Status and Future Perspective

1Department of Physiology, College of Medicine, University of Saskatchewan, 107 Wiggins Road, Saskatoon, SK, Canada S7N 5E5
2Division of Cardiovascular Medicine, Department of Medicine, Henry Ford Heart & Vascular Institute, 2799 West Grand Boulevard, Detroit, MI 48202, USA

Received 10 June 2013; Accepted 10 June 2013

Copyright © 2013 Joseph Fomusi Ndisang and Sharad Rastogi. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. V. S. Malik, W. C. Willett, and F. B. Hu, “Global obesity: trends, risk factors and policy implications,” Nature Reviews Endocrinology, vol. 9, pp. 13–27, 2013.
  2. J. C. Han, D. A. Lawlor, and S. Y. Kimm, “Childhood obesity,” The Lancet, vol. 375, no. 9727, pp. 1737–1748, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. S. C. Springer, J. Silverstein, K. Copeland, et al., “Management of type 2 diabetes mellitus in children and adolescents,” Pediatrics, vol. 131, pp. 648–664, 2013.
  4. E. V. Kuklina, X. Tong, M. G. George, and P. Bansil, “Epidemiology and prevention of stroke: a worldwide perspective,” Expert Review of Neurotherapeutics, vol. 12, no. 2, pp. 199–208, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Kataoka, Y. Aimi, R. Yanagisawa, et al., “Alumediated nonallelic homologous and nonhomologous recombination in the BMPR2 gene in heritable pulmonary arterial hypertension,” Genetics in Medicine, 2013. View at Publisher · View at Google Scholar
  6. C. Fiorillo, G. Brisca, D. Cassandrini, et al., “Subclinical myopathy in a child with neutral lipid storage disease and mutations in the PNPLA2 gene,” Biochemical and Biophysical Research Communications, vol. 430, pp. 241–244, 2013.
  7. J. F. Ndisang, “Role of heme oxygenase in inflammation, insulin-signalling, diabetes and obesity,” Mediators of Inflammation, vol. 2010, Article ID 359732, 18 pages, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Reyman, A. A. Verrijn Stuart, M. van Summeren, et al., “Vitamin D deficiency in childhood obesity is associated with high levels of circulating inflammatory mediators, and low insulin sensitivity,” International Journal of Obesity, 2013. View at Publisher · View at Google Scholar
  9. D. H. Wei, X. L. Zhang, R. Wang, et al., “Oxidized lipoprotein(a) increases endothelial cell monolayer permeability via ROS generation,” Lipids, vol. 48, pp. 579–586, 2013.
  10. C. Lackner, “Hepatocellular ballooning in nonalcoholic steatohepatitis: the pathologist's perspective,” Expert Review of Gastroenterology and Hepatology, vol. 5, no. 2, pp. 223–231, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. M. J. Lee, P. Pramyothin, K. Karastergiou, and S. K. Fried, “Deconstructing the roles of glucocorticoids in adipose tissue biology and the development of central obesity,” Biochimica et Biophysica Acta, 2013. View at Publisher · View at Google Scholar
  12. J. F. Ndisang and R. Wang, “Novel therapeutic strategies for impaired endothelium-dependent vascular relaxation,” Expert Opinion on Therapeutic Patents, vol. 12, no. 8, pp. 1237–1247, 2002. View at Publisher · View at Google Scholar · View at Scopus
  13. The Diabetes Control and Complications Trial Research Group, “The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus,” The New England Journal of Medicine, vol. 329, pp. 977–986, 1993.
  14. S. Genuth, “Insights from the diabetes control and complications trial/epidemiology of diabetes interventions and complications study on the use of intensive glycemic treatment to reduce the risk of complications of type 1 diabetes,” Endocrine Practice, vol. 12, supplement 1, pp. 34–41, 2006. View at Scopus
  15. J. J. Sim, S. K. Bhandari, J. Shi et al., “Plasma Renin Activity (PRA) levels and antihypertensive drug use in a large healthcare system,” American Journal of Hypertension, vol. 25, no. 3, pp. 379–388, 2012. View at Publisher · View at Google Scholar · View at Scopus